We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.George, JN, Shattil, SJ. The clinical importance of acquired abnormalities of platelet function. New Eng J Med1991; 324(1): 27–39.CrossRefGoogle ScholarPubMed
2
2.Storrie, MC, Scher, M, McGuire, J, Bokan, J. Thrombocytopenia in the absence of leukopenia associated with the use of neuroleptics. J Clin Psychiat1978; 39: 779–81.Google ScholarPubMed
5.Assion, HJ, Kolbinger, HM, Rao, ML. Laux, G. Lymphocytopenia and thrombocytopenia during treatment with risperidone or clozapine. Pharmacopsychiatry1996; 29(6): 227–8.CrossRefGoogle ScholarPubMed
6
6.Lowy, A, Wilson, A, Sachdev, P, Lindeman, R. Disseminated intravascular coagulopathy and thrombocytopenia associated with clozapine-induced neuroleptic malignant syndrome. Aust NZ J Med1995; 25: 368.CrossRefGoogle ScholarPubMed
7
7.Shawver, JR, Tarnowski, SM. Thrombocytopenia in prolonged chlorpromazine therapy. Am J Psychiatry1960; 116: 845CrossRefGoogle ScholarPubMed
9.Mahmood, T, Silverstone, T, Spittle, B. Risperidone appears safe in patients with anti-psychotic blood dyserasias. Int Clin Psychopharmacology1996; 11: 53–4.CrossRefGoogle Scholar
10
10.Young, A, Kehoe, R. Two cases of agranulocytosis on addition of a butryphenone to a longstanding course of phenothiazine treatment. Br J Psychiatry1989;154:710–2.CrossRefGoogle ScholarPubMed